Peter Obesso, DO
Sleep Medicine · Tyler, TXNPI 1356577787
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $22,586 of the $33,971 with a category attached, or 66.5%. 15 manufacturers reported payments, led by Idorsia Pharmaceuticals US Inc at 56.9% of the total. Reporting peaked in 2023 at $11,060 and has fallen 61.4% since, to $4,273 in 2025. Among sleep medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 251 payments — averaging $135.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Idorsia Pharmaceuticals US Inc$19K
- Axsome Therapeutics, Inc.$7K
- ZOLL Respicardia, Inc.$3K
- Inspire Medical Systems, Inc.$2K
- Jazz Pharmaceuticals Inc.$1K
- Harmony Biosciences LLC$826
- plus $632 from 9 others
What the payments were for
- Consulting fees$1,9136%
- Speaking & faculty fees$22,58666%
- Travel & lodging$2,9509%
- Food & beverage$6,01018%
- Education$5112%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Idorsia Pharmaceuticals US Inc | 42 | $19,314 |
| Axsome Therapeutics, Inc. | 50 | $7,235 |
| ZOLL Respicardia, Inc. | 13 | $2,585 |
| Inspire Medical Systems, Inc. | 22 | $2,202 |
| Jazz Pharmaceuticals Inc. | 42 | $1,176 |
| Harmony Biosciences LLC | 56 | $826 |
| Merck | 12 | $235 |
| Eisai Inc. | 1 | $125 |
| Avadel CNS Pharmaceuticals, LLC | 5 | $88 |
| Itamar Medical Inc | 1 | $64 |
| 3b Medical, Inc. | 3 | $30 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $26 |
| Fisher & Paykel Healthcare Inc | 1 | $24 |
| Philips North America LLC | 1 | $23 |
| Pfizer | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QUVIVIQ$18,659
- SUNOSI$5,573
- remede System$2,280
- Auvelity$1,125
- Inspire Upper Airway Stimulation System$904
- Inspire$890
- XYWAV$226
How this compares
$33,971 in reported general payments places this provider in the 90th percentile of 112 sleep medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelsomraSuvorexant | 37 | $18,451 |
| DayvigoLemborexant | 24 | $10,467 |
| Modafinil | 23 | $8,298 |
| Armodafinil | 13 | $1,351 |
| Temazepam | 88 | $1,212 |
| Ropinirole Hcl | 77 | $1,209 |
| Doxepin Hcl | 19 | $889 |
| Zolpidem Tartrate | 113 | $809 |
| Prazosin Hcl | 19 | $720 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 33 | $637 |
| Eszopiclone | 50 | $511 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 17 | $501 |
| Clonazepam | 36 | $438 |
| Gabapentin | 25 | $370 |
| Zaleplon | 17 | $179 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckBelsomra | $235 | $18,45137 claims |
| Eisai Inc.Dayvigo | $125 | $10,46724 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 112 sleep medicine providers in Texas.
Other sleep medicine in Tyler
- Sherri Ten PasTyler$4K
- Raghavendra GhugeTyler$3K
- Venu ParachuriTyler$2K
- Gerard MeskillSugar Land$1M
- Vikas JainFrisco$673K
- Amit VermaHouston$493K
- Jerald SimmonsHouston$165K
- James AndrySan Antonio$100K
- William BurkesBeaumont$99K
- Ashwin GowdaAustin$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.